Results 71 to 80 of about 53,302 (297)

Botulinum toxin type A for the management of glabellar rhytids

Clinical, Cosmetic and Investigational Dermatology, 2010
Anne Marie Tremaine, Jerry L McCulloughDepartment of Dermatology, University of California, Irvine, CA, USAAbstract: There is an increasing demand for minimally-invasive cosmetic procedures to arrest the aging process.
Anne Marie Tremaine, Jerry L McCullough
doaj  

The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review

eJournal of Oral Maxillofacial Research, 2020
Objectives: The purpose of this article is to systematically review the use, efficacy, differences between botulinum toxin type A doses and side effects of botulinum toxin type A therapy in patients with trigeminal neuralgia. Material and Methods: The
Anton Rubis, Gintaras Juodzbalys
doaj   +1 more source

Botulinum toxin type A in the treatment of Raynaud’s phenomenon: A three-year follow-up study

European Journal of Rheumatology, 2018
Objective Raynaud’s phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress. It causes an important reduction in the patient’s quality of life when severe. The available treatments do not always offer favorable
S. Medina, A. Gómez‐Zubiaur, N. Valdeolivas-Casillas, I. Polo-Rodríguez, L. Ruíz, Carmen Izquierdo, C. Guirado, Alicia Cabrera, L. Trasobares   +8 more
semanticscholar   +1 more source

From Disability to Diagnosis: Baseline Findings from the Calgary Functional Movement Disorder Registry

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Functional movement disorder (FMD), a subtype of functional neurological disorder, is a complex neuropsychiatric syndrome characterized by inconsistent and incongruent motor symptoms. Despite its relatively high prevalence, FMD remains associated with delayed diagnosis, significant disability, and limited evidence to guide ...
Andrea Soumbasis, Brian Steele, Megan Howlett, Kate Kain, Davide Martino, Kimberly G. Williams, Gabriela S. Gilmour   +6 more
wiley   +1 more source

Single Application of A2 NTX, a Botulinum Toxin A2 Subunit, Prevents Chronic Pain Over Long Periods in Both Diabetic and Spinal Cord Injury–Induced Neuropathic Pain Models

Journal of Pharmacological Sciences, 2012
Botulinum toxin type A is a unique candidate for inhibition of pain transmission. In the present study we attempted to see the beneficial actions of A2 neurotoxin (NTX), an active subunit of botulinum toxin type A.
Lin Ma, Jun Nagai, Yuki Sekino, Yoshitaka Goto, Shinji Nakahira, Hiroshi Ueda   +5 more
doaj   +1 more source

Global Aesthetics Consensus: Botulinum Toxin Type A—Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications

Plastic and Reconstructive Surgery, 2015
Background: Botulinum toxin type A injection remains the leading nonsurgical cosmetic procedure worldwide, with a high rate of efficacy and patient satisfaction.
H. Sundaram, M. Signorini, S. Liew, A. R. Trindade de Almeida, Yan Wu, André Vieira Braz, S. Fagien, G. Goodman, G. Monheit, H. Raspaldo   +9 more
semanticscholar   +1 more source

Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations

Movement Disorders, EarlyView.
Abstract Background Spastic paresis, resulting from central nervous system lesions, significantly impairs functional performance. In the framework of the International Classification of Functioning, Disability, and Health, functional performance was defined as functioning at the activity level in relation to the impairment of body functions and ...
Martina Hoskovcova, Marjolaine Baude, Bo Biering‐Sørensen, Ota Gal, Mary P Galea, Jean‐Michel Gracies, Carmen Rodriguez‐Blazquez, Theodore Wein, Michelle Hyczy de Siqueira Tosin, Álvaro Sánchez‐Ferro, Tiago A Mestre, Matej Skorvanek, Robert Jech, The members of the MDS Clinical Outcome Assessments Scientific Evaluation Committee and MDS Spasticity Study Group   +13 more
wiley   +1 more source

The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea

Turkish Archives of Otorhinolaryngology, 2018
Objective: The aim of this study was to evaluate the effect of Botulinum toxin type A by injecting in the submandibular and parotid glands on the frequency and severity of sialorrhea.Methods: Pediatric patients who were referred to our department with ...
Özgür Sürmelioğlu, Muhammed Dağkıran, Ülkü Tuncer, Süleyman Özdemir, Özgür Tarkan, Fikret Çetik, Mete Kıroğlu   +6 more
doaj   +1 more source

EVALUATION OF BOTULINUM TOXIN ON BITE FORCE DISTRIBUTION AND MUSCLES ACTIVITY IN BRUXISM (SINGLE ARM CLINICAL TRIAL) [PDF]

Alexandria Dental Journal
Background: Bruxism, a parafunctional activity involving teeth grinding or jaw clenching, often leads to dental and musculoskeletal problems. Conventional treatments often only treat symptoms.
Marwa Mohamed, Ragab Hassan, Gaffar El Halawani, Walaa Elwakil   +3 more
doaj   +1 more source

Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

Annals of Neurology, 2016
To evaluate the analgesic effect of botulinum toxin type A (BTX‐A) on patients with spinal cord injury‐associated neuropathic pain.
Zee A. Han, D. Song, H. Oh, M. Chung
semanticscholar   +1 more source